If Medivation Is Sold, Brean Thinks It'll Be For Far More Than Sanofi's Bid By: Benzinga via Benzinga May 06, 2016 at 10:29 AM EDT Medivation Inc (NASDAQ: MDVN) reported its U.S. and ex-U.S. Xtandi sales for 1Q16 in line with the consensus. Brean Capital’s ... Read More >> Related Stocks: Sanofi-Aventis S.A. ADR